As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 27, 2026 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended June 30, 2026.

JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the Period from 01 April 2026 to 30 June 2026. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/JMI%20Hospital826.pdf

JMI Hospital Requisite Manufacturing Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 January 2026 to March 31, 2026. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/JMI26.pdf

(Q3 Un-audited): Consolidated EPS was Tk. 0.18 for January-March 2026 as against Tk. 0.50 for January-March 2025; Consolidated EPS was Tk. 0.67 for July 2025-March 2026 as against Tk. 1.56 for July 2024-March 2025. Consolidated NOCFPS was Tk. 0.29 for July 2025-March 2026 as against Tk. 0.75 for July 2024-March 2025. Consolidated NAV per share was Tk. 35.47 as on March 31, 2026 and Tk. 35.14 as on June 30, 2025. Reasons for Deviation: EPS has decreased because imported raw materials purchases are at high prices compared with sales in the local market

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 28, 2026 at 4:00 pm to consider, among others, Un-Audited Financial Statements for the Third Quarter (Q3) period ended March 31, 2026.

The Company has informed that it has disbursed the Cash Dividend for the year ended June 30, 2025 to the respective shareholders.

JMI Hospital Requisite Mfg. Ltd. submitted auditor's report regarding status of IPO (Initial Public Offering) Proceeds utilization statement for the period from 01 October 2025 to 31 December, 2025. To view the details, please visit: https://www.dsebd.org/Auditors_opinion/2025/JMI%20Hospital%20Requisite_25.pdf

(Q2 Un-audited): Consolidated EPS was Tk. 0.21 for October-December 2025 as against Tk. 0.51 for October-December 2024; Consolidated EPS was Tk. 0.49 for July-December 2025 as against Tk. 1.06 for July-December 2024. Consolidated NOCFPS was Tk. 0.29 for July-December 2025 as against Tk. 0.36 for July-December 2024. Consolidated NAV per share was Tk. 35.63 as on December 31, 2025 and Tk. 35.14 as on June 30, 2025. Reasons for deviation: EPS decreased because imported raw material purchases are at high prices compared with sales in the local market.

The Company will be placed in 'B' category from existing 'A' category with effect from January 25, 2026 as the Company has approved 5% Cash Dividend for the year ended June 30, 2025.

The company has informed that the shareholders at its 17th AGM held on January 22, 2026, approved the revision of IPO proceeds utilization along with an extension of time up to December 31, 2026. To view details, please visit the following link: https://www.dsebd.org/Annexure/2025/PSI_17th_AGM_IPO_Proceeds_JMI_2026.pdf